Similarly, in two lines of primary colon cancer cells (patient-derived), icaritin (10 μM) treatment induced Beclin-1, ATG-5 and LC3B-II upregulation but p62 degradation (Figure 1C). This evidence concerns the gene BECN1 and malignant colon neoplasm.